missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CD59 Polyclonal Antibody, Invitrogen™
Rabbit Polyclonal Antibody
162.00 CHF - 344.00 CHF
Spezifikation
| Antigen | CD59 |
|---|---|
| Konzentration | 0.5 mg/mL |
| Anwendungen | Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot |
| Klassifikation | Polyclonal |
| Konjugat | Unconjugated |
| Produktcode | Marke | Menge | Preis | Menge & Verfügbarkeit | |||||
|---|---|---|---|---|---|---|---|---|---|
| Produktcode | Marke | Menge | Preis | Menge & Verfügbarkeit | |||||
|
17948942
|
Invitrogen
PA5145340 |
20 μL |
162.00 CHF
20 Mikroliter |
Verfügbar ab: 23-01-2025
Loggen Sie sich ein, um den Lagerbestand zu sehen |
|||||
|
17969602
|
Invitrogen
PA5145339 |
200 μL |
344.00 CHF
200 Mikroliter |
Verfügbar ab: 23-01-2025
Loggen Sie sich ein, um den Lagerbestand zu sehen |
|||||
Beschreibung
CD59 (Protectin) is a small (18-20 kDa) GPI-anchored ubiquitously expressed inhibitor of the membrane attack complex (MAC). CD59 is the key regulator that preserves the autologous cells from terminal effector mechanism of the complement cascade. CD59 also associates with C5b-8 complex and counteracts appropriate formation of cytolytic pore within the plasma membrane. Further, CD59 is a low-affinity ligand of human CD2, causes T cell costimulation, and is involved in lymphocyte signal transduction. CD59 is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. Mutations in this gene cause CD59 deficiency, a disease involving hemolytic anemia, thrombosis, and cerebral infarction. Multiple alternatively spliced transcript variants of CD59 have been identified.Spezifikation
| CD59 | |
| Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot | |
| Unconjugated | |
| Rabbit | |
| Human, Mouse | |
| O55186, P13987, P58019 | |
| 12509, 333883, 966 | |
| Recombinant Mouse CD59 protein, Val22-Ser96 (Accession #O55186) | |
| Primary | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
| 0.5 mg/mL | |
| Polyclonal | |
| Liquid | |
| RUO | |
| PBS with 50% glycerol and 0.05% Proclin 300, pH 7.4 | |
| 16.3A5, 1F5, 1F5 antigen, 20 kDa homologous restriction factor, AA987121, Cb59b molecule, CD59, CD59 antigen, CD59 antigen p18-20 (antigen identified by monoclonal antibodies 16.3A5, EJ16, EJ30, EL32 and G344), CD59 glycoprotein, CD59 molecule, CD59 molecule (CD59 blood group), CD59 molecule, complement regulatory protein, Cd59a, CD59a antigen, CD59A glycoprotein, Cd59b, CD59b antigen, CD59B glycoprotein, CD59b moleucle, complement regulatory protein, complement inhibitor CD59, complement regulatory protein, EJ16, EJ30, EL32, G344, HRF20, HRF-20, human leukocyte antigen MIC11, Ly-6-like protein, lymphocytic antigen CD59/MEM43, MACIF, MAC-inhibitory protein, MACIP, MAC-IP, MEM43, MEM43 antigen, membrane attack complex (MAC) inhibition factor, membrane attack complex inhibition factor, Membrane inhibitor of reactive lysis, MIC11, MIN1, MIN2, MIN3, MIRL, MSK21, p18-20, protectin, surface anitgen recognized by monoclonal antibody 16.3A5, T cell-activating protein | |
| CD59, Cd59a, Cd59b | |
| IgG | |
| Protein A | |
| CD59 |
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts